KRISTY SOLIS: Open Payments
NPI 1215584552 · HENDERSON, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,930 in 158 payments from 31 companies in 2025. Trend: 2023 $4,806 · 2024 $3,861 · 2025 $2,930
Food & beverage: $2,887Education: $43
| Company | Payments | Amount |
|---|---|---|
| Xeris Pharmaceuticals, Inc. | 15 | $252 |
| Novo Nordisk Inc | 10 | $225 |
| RECORDATI_RARE_DISEASES_INC. | 10 | $201 |
| Amgen Inc. | 14 | $198 |
| Radius Health, Inc. | 9 | $179 |
| ABBVIE INC. | 10 | $165 |
| Bayer Healthcare Pharmaceuticals Inc. | 24 | $163 |
| BETA BIONICS, INC. | 5 | $150 |
| Ascendis Pharma Endocrinology Inc | 6 | $138 |
| Neurocrine BioSciences, Inc. | 4 | $118 |
Products named: Ozempic, ISTURISA, Tymlos, UBRELVY, Kerendia, GVOKE HYPOPEN, iLet Bionic Pancreas, Yorvipath.
Industry payments across NV — which companies pay providers there.
